Association of Reperfusion and Procedural Characteristics with Endovascular Thrombectomy Outcomes in Large Core Stroke: Sub‐Analysis from the SELECT2 Trial

冲程(发动机) 医学 芯(光纤) 内科学 血管内治疗 心脏病学 外科 计算机科学 动脉瘤 电信 机械工程 工程类
作者
A. Hassan,Michael Abraham,Spiros Blackburn,Muhammad Shazam Hussain,Mahmoud Dibas,Michael Chen,Yin Hu,Deep Pujara,Nabeel Herial,Jenny P. Tsai,Ronald F. Budzik,Nathan Manning,Osman Kozak,Ricardó A. Hanel,Amin N. Aghaebrahim,Chirag D. Gandhi,Fawaz Al‐Mufti,Andrew Cheung,Bernard Yan,Peter Mitchell
出处
期刊:Annals of Neurology [Wiley]
卷期号:97 (1): 175-184 被引量:2
标识
DOI:10.1002/ana.27104
摘要

Endovascular thrombectomy (EVT) was shown to be safe and efficacious in patients with large core stroke in multiple randomized controlled trials. However, the impact of reperfusion and other procedural metrics on EVT outcomes in this population has not been well‐characterized. Methods From the SELECT2 trial, we evaluated the association between reperfusion status, first‐pass effect (near‐complete or complete reperfusion [extended thrombolysis in cerebral infarction (eTICI) 2c‐3] in 1 pass), procedure time and primary technique (aspiration vs stent‐retriever) with functional outcomes in patients receiving EVT across ASPECTS (3 vs 4 vs 5) and core estimate strata (<70 vs ≥70ml, <100 vs ≥100ml, and <150 vs ≥150ml). Results Of 180 patients who received thrombectomy, 144 (80%) achieved successful reperfusion (eTICI 2b‐3) and demonstrated better clinical outcomes (adjusted generalized odds ratios [aGenOR]: 1.48, 95% confidence interval [CI]: 1.01–2.15), compared with unsuccessful reperfusion. Results were consistent across ASPECTS and core estimate strata. Additionally, complete or near‐complete reperfusion (eTICI 2c‐3) was associated with better functional outcome (aGenOR: 1.99, 95% CI: 1.33–2.97) in patients achieving successful reperfusion. Functional outcome point estimates favored those with first‐pass‐effect (42 of 167 (25%), aGenOR: 1.46, 95% CI: 0.96–2.24). Longer procedure time was associated with worse modified Rankin scale (mRS) distribution (aGenOR: 0.92, 95% CI: 0.87–0.96, p ‐value = 0.001 for 10 minutes increment). Aspiration‐first technique was used in 43 of 154 (25%) patients and was not associated with higher reperfusion (88% vs 78%, p = 0.18) or better functional outcome (aGenOR: 0.74, 95% CI: 0.50–1.10) as compared with stent‐retriever first. Interpretation Successful reperfusion resulted in improved clinical outcomes in large core patients across baseline ischemic core strata. Near complete or complete reperfusion was further associated with better outcomes, whereas prolonged procedures were associated with worse outcomes. Results were consistent regardless of the technique used. ANN NEUROL 2025;97:175–184
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
NEXUS1604完成签到,获得积分10
1秒前
搜集达人应助小白采纳,获得10
2秒前
海鸥跳海发布了新的文献求助10
2秒前
无花果应助老雪半糖加冰采纳,获得10
2秒前
Guangjie920完成签到,获得积分10
3秒前
雨田发布了新的文献求助10
3秒前
XiaoMaomi完成签到,获得积分10
4秒前
wanci应助单薄雅阳采纳,获得10
4秒前
4秒前
5秒前
QianYang发布了新的文献求助50
6秒前
6秒前
wwwwppp完成签到,获得积分10
7秒前
7秒前
asdfzxcv应助小刚纸采纳,获得10
8秒前
满_1999发布了新的文献求助50
9秒前
科研龙完成签到 ,获得积分10
9秒前
alex完成签到,获得积分10
9秒前
123完成签到,获得积分20
9秒前
10秒前
10秒前
Archy完成签到,获得积分10
11秒前
11秒前
方方土发布了新的文献求助10
11秒前
14秒前
量子星尘发布了新的文献求助10
14秒前
14秒前
14秒前
15秒前
呵呵呵呵发布了新的文献求助10
15秒前
科研通AI6应助芋泥丸丸采纳,获得10
16秒前
隐形曼青应助科研通管家采纳,获得10
17秒前
17秒前
arniu2008应助lawang采纳,获得10
17秒前
浮游应助科研通管家采纳,获得10
17秒前
17秒前
面壁思过应助科研通管家采纳,获得10
17秒前
浮游应助科研通管家采纳,获得10
17秒前
浮游应助科研通管家采纳,获得10
17秒前
小蘑菇应助科研通管家采纳,获得10
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Binary Alloy Phase Diagrams, 2nd Edition 8000
Comprehensive Methanol Science Production, Applications, and Emerging Technologies 2000
From Victimization to Aggression 1000
Translanguaging in Action in English-Medium Classrooms: A Resource Book for Teachers 700
Exosomes Pipeline Insight, 2025 500
Red Book: 2024–2027 Report of the Committee on Infectious Diseases 500
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5653296
求助须知:如何正确求助?哪些是违规求助? 4789685
关于积分的说明 15063648
捐赠科研通 4811856
什么是DOI,文献DOI怎么找? 2574143
邀请新用户注册赠送积分活动 1529815
关于科研通互助平台的介绍 1488524